Active, not recruitingPHASE2, PHASE3NCT02984124
Communication During Hospitalization About Resuscitation Trial
Studying Papillary renal cell carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Vermont
- Principal Investigator
- Renee Stapleton, MD PhDUniversity of Vermont
- Intervention
- Informed Assent Discussion(behavioral)
- Enrollment
- 182 target
- Eligibility
- 65 years · All sexes
- Timeline
- 2016 – 2025
Study locations (4)
- University of North Carolina, Chapel Hill, North Carolina, United States
- Medical University of South Carolina, Charleston, South Carolina, United States
- University of Vermont, Burlington, Vermont, United States
- University of Washington, Seattle, Washington, United States
Collaborators
University of Washington · Medical University of South Carolina · University of North Carolina, Chapel Hill
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02984124 on ClinicalTrials.govOther trials for Papillary renal cell carcinoma
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT07586332INVESTIGATION OF THE GENETIC ETIOLOGY OF HERNIA SAC DEVELOPMENT IN MALE CHILDREN WITH UNDESCENDED TESTIS AND INGUINAL HERNIATrakya University
- RECRUITINGNCT06956144Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer PatientsThe First Affiliated Hospital of Xiamen University
- RECRUITINGNCT06532422Study of Post-operative Complications After Laparoscopic Outpatient NephrectomyGCS Ramsay Santé pour l'Enseignement et la Recherche
- RECRUITINGNANCT06542484The Real-world Treatment Satisfaction by Gefapixiant in RCCNagoya City University
- RECRUITINGPHASE3NCT06467097Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell CarcinomaSamsung Medical Center
- RECRUITINGPHASE4NCT05805436Preop Laxatives in Robotic Urologic SurgeryChad R. Tracy
- ACTIVE NOT RECRUITINGPHASE1NCT05704985Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ TumorsDEKA Biosciences
- ACTIVE NOT RECRUITINGPHASE2NCT05411081Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 TrialNational Cancer Institute (NCI)